Monash rare disease drug trial gets $1.5 million boost

A/Prof David Curtis, left, in clinic.
Still from Monash University at AMREP video

by Anne Crawford

Monash University researchers will start a national clinical trial into a new treatment for a life-threatening complication that follows bone marrow transplant, thanks to a $1.5
million federal government grant.

Associate Professor David Curtis was among four medical researchers from Monash University and The Alfred Hospital awarded more than $5.5million under the Medical Research Future Fund’s (MRFF) Rare Cancers, Rare Diseases and Unmet Needs Clinical Trials Program.